Enanta Pharmaceuticals shares are trading lower after it was announced the company will be replaced in the S&P SmallCap 600.
Portfolio Pulse from Benzinga Newsdesk
Enanta Pharmaceuticals will be replaced in the S&P SmallCap 600, causing its shares to trade lower.
September 05, 2023 | 5:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Enanta Pharmaceuticals' removal from the S&P SmallCap 600 has led to a decrease in its share price.
Being included in an index like the S&P SmallCap 600 often increases a stock's visibility and demand, as it is automatically included in certain index funds. Enanta Pharmaceuticals' removal from the index could decrease demand for its shares, leading to a lower share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100